Macquarie Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.5M | Buy |
2,095,235
+2,003,713
| +2,189% | +$86.5M | 0.11% | 261 |
|
|
2025
Q1 | $3.16M | Buy |
+91,522
| New | +$3.16M | ﹤0.01% | 1091 |
|
|
2022
Q4 | – | Sell |
-1,210
| Closed | -$18K | – | 1807 |
|
|
2022
Q3 | $18K | Sell |
1,210
-589
| -33% | -$8.76K | ﹤0.01% | 2219 |
|
|
2022
Q2 | $16K | Hold |
1,799
| – | – | ﹤0.01% | 2359 |
|
|
2022
Q1 | $18 | Hold |
1,799
| – | – | ﹤0.01% | 2403 |
|
|
2021
Q4 | $30K | Hold |
1,799
| – | – | ﹤0.01% | 2295 |
|
|
2021
Q3 | $84K | Hold |
1,799
| – | – | ﹤0.01% | 2033 |
|
|
2021
Q2 | $110K | Hold |
1,799
| – | – | ﹤0.01% | 1946 |
|
|
2021
Q1 | $111K | Buy |
+1,799
| New | +$111K | ﹤0.01% | 1873 |
|